• No results found

Treatment Resistant Schizophrenia

Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment

Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment

... in schizophrenia patients. It has been reported that schizophrenia patients who are tobacco smokers have better cognitive performances compared to those who are ...in treatment-resistant ...

8

Role of aripiprazole in treatment-resistant schizophrenia

Role of aripiprazole in treatment-resistant schizophrenia

... with schizophrenia respond unsatisfactorily to antip- sychotic treatment and are termed ...for treatment-resistant schizophrenia, drugs with different pharmacological profiles seem to ...

10

Studies on the Association between Genetic Polymorphisms and Clozapine Drug Response in Treatment Resistant Schizophrenia.

Studies on the Association between Genetic Polymorphisms and Clozapine Drug Response in Treatment Resistant Schizophrenia.

... disorders, schizophrenia, other psychoses, mood disorders, and anxiety ...with schizophrenia are initially treated with either dopamine antagonists or serotonin dopamine ...with ...

258

Is treatment resistant schizophrenia categorically distinct from treatment responsive schizophrenia? a systematic review

Is treatment resistant schizophrenia categorically distinct from treatment responsive schizophrenia? a systematic review

... (6 resistant, 8 responsive) and found that treatment-responders had significantly lower levels of N- acetyl aspartate (NAA) in the anterior cingulate cortex (ACC) than both treatment-resistant ...

14

Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials

Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials

... in schizophrenia for clinicians, researchers and ...with schizophrenia that is unresponsive to treatment?” ...with treatment resistant ...

8

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics

... with schizophrenia do not respond to two (or more) trials of dopaminergic ...have treatment-resistant schizophrenia ...effective treatment for TRS, although it is underused in clinical ...

13

Experiences, attitudes, and perceptions of caregivers of individuals with treatment resistant schizophrenia: a qualitative study

Experiences, attitudes, and perceptions of caregivers of individuals with treatment resistant schizophrenia: a qualitative study

... of schizophrenia [2], the key focus of AP treatment ...[3]. Schizophrenia that is non-responsive to treatment with an atypical or typical antipsychotic (AP), resulting in persistent positive ...

13

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia

Influence of <em>5-HT1A</em> and <em>5-HTTLPR</em> genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia

... The present study examined the influence of two genetic polymorphisms in the 5-HT1A gene and SLC6A4 gene on clinical symptoms and treatment resistance in patients with schizophrenia. The 5-HT1A rs6295 and ...

7

Pharmacotherapy for treatment-resistant schizophrenia

Pharmacotherapy for treatment-resistant schizophrenia

... label treatment with clozapine (n = ...Because treatment allocation was known to both clinicians and participants there may have been reluctance to discon- tinue clozapine, it being widely considered the ...

15

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists

<p>Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists</p>

... obviously treatment resis- tant or who were receiving clozapine (the only currently approved medication for ...and treatment variables that are intrinsi- cally associated with schizophrenia, that ...

13

Demographic Profile and Management Strategies of Treatment Resistant Schizophrenia and Treatment Resistant Depression in a Tertiary Care Referral Hospital

Demographic Profile and Management Strategies of Treatment Resistant Schizophrenia and Treatment Resistant Depression in a Tertiary Care Referral Hospital

... for treatment-resistant MDD patients in acute phase studies published to ...in Treatment-resistant ...the treatment or could be mild with fewer risks of ...failed treatment with ...

126

First episode psychosis in treatment resistant schizophrenia: a cross sectional study of a long term follow up cohort

First episode psychosis in treatment resistant schizophrenia: a cross sectional study of a long term follow up cohort

... of treatment refractoriness, were similar or rather shorter than those of the Non-TRS group, indicating that there was no relationship between DUP and future develop- ment to ...

10

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment resistant schizophrenia

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment resistant schizophrenia

... competitive treatment strategies is adopted; (c) the multicentre design, nested into everyday clinical practice, has been creating a situa- tion where investigators simultaneously act both as physi- cians and ...

9

Early Treatment Response in First Episode Psychosis: A 7-Tesla Magnetic Resonance Spectroscopic Study of Glutathione and Glutamate

Early Treatment Response in First Episode Psychosis: A 7-Tesla Magnetic Resonance Spectroscopic Study of Glutathione and Glutamate

... of treatment resistant schizophrenia, there are some limitations that should be ...antipsychotic treatment and ACC glutamate levels in patients with FEP after one (Szulc et al, 2005), thirty ...

115

Schizophrenia: the issue of informed consent to treatment with clozapine

Schizophrenia: the issue of informed consent to treatment with clozapine

... to treatment with clozapine in treatment-resistant ...disorders, treatment- related decision making abilities show a high degree of variability, and there is the need to evaluate competence to ...

7

Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens

Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens

... cin resistant (RR)-TB treatment regimens, which lasts for 20 – 24 months and achieved a success rate nearly in 50% of patients, worldwide ...prolonged treatment period, low drug efficacy and toxic ...

10

Lack of tolerable treatment options for patients with schizophrenia

Lack of tolerable treatment options for patients with schizophrenia

... AA treatment options for their patients due to the combined effect of heterogeneity of patient type and heterogeneity of AA treatment ...with schizophrenia, where much attention has been placed on ...

10

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

... during treatment with antipsychotics tend to experience adverse emotional consequences similar to those noted among women who gain weight in the general popula- ...between treatment-emergent weight gain and ...

13

Atypical antipsychotics in the treatment of early-onset schizophrenia

Atypical antipsychotics in the treatment of early-onset schizophrenia

... studies. Treatment of EOS with ziprasidone failed to differentiate itself from the placebo group; however, ziprasidone was generally well tolerated, with a neutral weight and metabolic ...

7

Dermatoglyphic patterns as predictors of treatment response in Schizophrenia.

Dermatoglyphic patterns as predictors of treatment response in Schizophrenia.

... The study of dermatoglyphic abnormalities has been employed in a number of chromosomal disorders, congenital malformations, and neurological and neuropsychiatric conditions in order to gain insight into the complex ...

75

Show all 10000 documents...

Related subjects